Prediction of MHC class I binding peptides using profile motifs - PubMed (original) (raw)
Prediction of MHC class I binding peptides using profile motifs
Pedro A Reche et al. Hum Immunol. 2002 Sep.
Abstract
Peptides that bind to a given major histocompatibility complex (MHC) molecule share sequence similarity. Therefore, a position specific scoring matrix (PSSM) or profile derived from a set of peptides known to bind to a specific MHC molecule would be a suitable predictor of whether other peptides might bind, thus anticipating possible T-cell epitopes within a protein. In this approach, the binding potential of any peptide sequence (query) to a given MHC molecule is linked to its similarity to a group of aligned peptides known to bind to that MHC, and can be obtained by comparing the query to the PSSM. This article describes the derivation of alignments and profiles from a collection of peptides known to bind a specific MHC, compatible with the structural and molecular basis of the peptide-MHC class I (MHCI) interaction. Moreover, in order to apply these profiles to the prediction of peptide-MHCI binding, we have developed a new search algorithm (RANKPEP) that ranks all possible peptides from an input protein using the PSSM coefficients. The predictive power of the method was evaluated by running RANKPEP on proteins known to bear MHCI K(b)- and D(b)-restricted T-cell epitopes. Analysis of the results indicates that > 80% of these epitopes are among the top 2% of scoring peptides. Prediction of peptide-MHC binding using a variety of MHCI-specific PSSMs is available on line at our RANKPEP web server (www.mifoundation.org/Tools/rankpep.html). In addition, the RANKPEP server also allows the user to enter additional profiles, making the server a powerful and versatile computational biology benchmark for the prediction of peptide-MHC binding.
Similar articles
- Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles.
Reche PA, Glutting JP, Zhang H, Reinherz EL. Reche PA, et al. Immunogenetics. 2004 Sep;56(6):405-19. doi: 10.1007/s00251-004-0709-7. Epub 2004 Sep 3. Immunogenetics. 2004. PMID: 15349703 - Prediction of peptide-MHC binding using profiles.
Reche PA, Reinherz EL. Reche PA, et al. Methods Mol Biol. 2007;409:185-200. doi: 10.1007/978-1-60327-118-9_13. Methods Mol Biol. 2007. PMID: 18450001 - Class I MHC-peptide interaction: structural and functional aspects.
Ruppert J, Kubo RT, Sidney J, Grey HM, Sette A. Ruppert J, et al. Behring Inst Mitt. 1994 Jul;(94):48-60. Behring Inst Mitt. 1994. PMID: 7998914 Review. - Structure of peptides associated with MHC class I molecules.
Engelhard VH. Engelhard VH. Curr Opin Immunol. 1994 Feb;6(1):13-23. doi: 10.1016/0952-7915(94)90028-0. Curr Opin Immunol. 1994. PMID: 7513522 Review.
Cited by
- Harnessing microbial antigens as cancer antigens: a promising avenue for cancer immunotherapy.
Zhang T, Zhang X, Chen J, Zhang X, Zhang Y. Zhang T, et al. Front Immunol. 2024 Jul 30;15:1411490. doi: 10.3389/fimmu.2024.1411490. eCollection 2024. Front Immunol. 2024. PMID: 39139570 Free PMC article. Review. - Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells.
Fernandez SA, Pelaez-Prestel HF, Fiyouzi T, Gomez-Perosanz M, Reiné J, Reche PA. Fernandez SA, et al. Front Immunol. 2024 Jul 18;15:1425374. doi: 10.3389/fimmu.2024.1425374. eCollection 2024. Front Immunol. 2024. PMID: 39091504 Free PMC article. - In Silico Immunogenicity Assessment of Therapeutic Peptides.
Li W, Wei J, Jiang Q, Zhou Y, Yan X, Xiang C, Huang J. Li W, et al. Curr Med Chem. 2024;31(26):4100-4110. doi: 10.2174/0109298673264899231206093930. Curr Med Chem. 2024. PMID: 38275064 Review. - Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus.
Bodas-Pinedo A, Lafuente EM, Pelaez-Prestel HF, Ras-Carmona A, Subiza JL, Reche PA. Bodas-Pinedo A, et al. Front Immunol. 2023 Aug 22;14:1235053. doi: 10.3389/fimmu.2023.1235053. eCollection 2023. Front Immunol. 2023. PMID: 37675108 Free PMC article. - In silico design and evaluation of a novel mRNA vaccine against BK virus: a reverse vaccinology approach.
Mohammadi Y, Nezafat N, Negahdaripour M, Eskandari S, Zamani M. Mohammadi Y, et al. Immunol Res. 2023 Jun;71(3):422-441. doi: 10.1007/s12026-022-09351-3. Epub 2022 Dec 29. Immunol Res. 2023. PMID: 36580228 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials